The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.2.473PMID 11154225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How cells respond to interferons.

  1998cited by this paper
• Type I IFNs enhance the terminal differentiation of dendritic cells.

  1998cited by this paper
• The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action.

  1997cited by this paper
• The Unusual Species Cross-reactivity of the Leukemia Inhibitory Factor Receptor α-Chain Is Determined Primarily by the Immunoglobulin-like Domain*

  1997cited by this paper
• Cloning and Characterization of Soluble and Transmembrane Isoforms of a Novel Component of the Murine Type I Interferon Receptor, IFNAR 2*

  1997cited by this paper
• The Short Form of the Interferon α/β Receptor Chain 2 Acts as a Dominant Negative for Type I Interferon Action*

  1997cited by this paper
• Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.

  1997cited by this paper
• Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2.

  1997cited by this paper
• Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.

  1996cited by this paper
• Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

  1996cited by this paper
• Alpha and beta interferons and their receptor and their friends and relations.

  1995cited by this paper
• A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses.

  1995cited by this paper
• α and α Interferons and Their Receptor and Their Friends and Relations

  1995cited by this paper
• Cloning and Expression of a Long Form of the β Subunit of the Interferon αβ Receptor That Is Required for Signaling (*)

  1995cited by this paper
• Ligand-induced association of the type I interferon receptor components

  1995cited by this paper
• Mutant U5A cells are complemented by an interferon‐alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster.

  1995cited by this paper
• The human interferon alpha/beta receptor: characterization and molecular cloning.

  1994cited by this paper
• Functional role of type I and type II interferons in antiviral defense.

  1994cited by this paper
• Cytokine therapeutics: lessons from interferon alpha.

  1994cited by this paper
• Soluble receptors for cytokines and growth factors: generation and biological function.

  1994cited by this paper
• Role of interferons in the regulation of cell proliferation, differentiation, and development

  1994cited by this paper
• Serum soluble interleukin‐6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin‐6 signal

  1993cited by this paper
• Inter‐species chimeras of leukaemia inhibitory factor define a major human receptor‐binding determinant.

  1993cited by this paper
• Affinity conversion of receptors for colony stimulating factors: properties of solubilized receptors.

  1992cited by this paper
• A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor.

  1992cited by this paper
• Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.

  1992cited by this paper
• Behavior of a cloned murine interferon alpha/beta receptor expressed in homospecific or heterospecific background.

  1992cited by this paper
• Functional analysis of interferon-α subtypes using monoclonal antibodies to interferon-α 4a—subtype reactivity, neutralisation of biological activities and epitope analysis

  1992cited by this paper
• Intermittent interferonemia and interferon responses in multiple sclerosis.

  1991cited by this paper
• Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.

  1990cited by this paper
• Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated

  1990cited by this paper
• pEF-BOS, a powerful mammalian expression vector.

  1990cited by this paper
• Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

  1989cited by this paper
• Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels

  1988cited by this paper
• Interferons and their actions.

  1987cited by this paper
• The interferon genes.

  1986cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper
• Transcripts from the Cellular Homologs of Retroviral Oncogenes: Distribution Among Chicken Tissues

  1982cited by this paper
• In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• In the Absence of Type-1 IFN, HSV-1 LAT Increases γ34.5 Expression and Enhances Mortality in Infected Mice

  2025cites this paper
• Mechanisms of Differential Signal Transduction by IFNLR1 Variants

  2025cites this paper
• Protein Post‐Translational Modification‐Mediated Control of Type I Interferon Cascade Signaling

  2025cites this paper
• The importance of IFNα2A (Roferon-A) in HSV-1 latency and T cell exhaustion in ocularly infected mice

  2024cites this paper
• Type I IFN in Glomerular Disease: Scarring beyond the STING

  2024cites this paper
• Recombinant soluble type I interferon receptor exerts antiviral activity by inducing proteins related to autophagy.

  2024cites this paper
• Regulation of human interferon signaling by transposon exonization.

  2024cites this paper
• Ubiquitination network in the type I IFN‐induced antiviral signaling pathway

  2023cites this paper
• Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling

  2023cites this paper
• Identification of a Novel Interferon Lambda Splice Variant in Chickens

  2023influential citation
• Regulation of human interferon signaling by transposon exonization

  2023cites this paper
• Soluble forms of cytokine and growth factor receptors: mechanisms of generation and modes of action in the regulation of local and systemic inflammation

  2022cites this paper
• Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment

  2021influential citation
• Double-edged effects of interferons on the regulation of cancer-immunity cycle

  2021cites this paper
• Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption

  2021cites this paper
• Efficient mutagenesis targeting the IFNAR1 gene in mice using a combination of Cas9 protein and dual gRNAs.

  2021cites this paper
• Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses

  2021cites this paper
• Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation

  2020influential citation
• Age-related transcriptional modules and TF-miRNA-mRNA interactions in neonatal and infant human thymus

  2020cites this paper
• Cloning and characterisation of type I interferon receptor 1 in orange-spotted grouper (Epinephelus coioides) for response to nodavirus infection.

  2020cites this paper
• Structural integrity with functional plasticity: what type I IFN receptor polymorphisms reveal

  2020cites this paper
• Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue

  2020cites this paper
• Antiviral RNAi in Insects and Mammals: Parallels and Differences

  2019cites this paper
• HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells

  2019influential citation
• Insights into leptin signaling and male reproductive health: the missing link between overweight and subfertility?

  2018cites this paper
• Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense

  2018cites this paper
• Higher Serum Levels of Type I Interferon Receptor in Adults with Chronic Hepatitis B Leading to Hepatitis B Surface Antigen Clearance

  2017influential citation
• Characterization of interferon α and β receptor IFNAR1 and IFNAR2 expression and regulation in the uterine endometrium during the estrous cycle and pregnancy in pigs.

  2017cites this paper
• Spontaneous germinal centers and autoimmunity

  2017cites this paper
• Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker

  2017cites this paper
• Leptin and Sertoli cells mitochondrial bioenergetics

  2017cites this paper
• Optimizing mouse models for precision cancer prevention

  2016cites this paper
• Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis.

  2016cites this paper
• A study of the chicken IFN lambda system

  2016cites this paper
• Cytokine Regulation of Metastasis and Tumorigenicity.

  2016cites this paper
• Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.

  2015cites this paper
• Classification and Treatment of Pancreatic and Non-Pancreatic Periampullary Cancers

  2015cites this paper
• Dynamic control of type I IFN signalling by an integrated network of negative regulators.

  2015cites this paper
• Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells

  2015cites this paper
• Interferons, Signal Transduction Pathways, and the Central Nervous System

  2014cites this paper
• Differential activation of dendritic cell subsets by Schistosoma mansoni

  2014cites this paper
• Production and Action of Type I Interferons in Host Defense

  2014cites this paper
• MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients

  2014cites this paper
• Impaired HCV Clearance in HIV/HCV Coinfected Subjects Treated with PegIFN and RBV Due to Interference of IFN Signaling by IFNαR2a

  2014cites this paper
• TLR4-Mediated Septic Shock Type I IFN Signaling and Exacerbates Soluble IFN Receptor Potentiates In Vivo

  2014cites this paper
• Soluble IFN Receptor Potentiates In Vivo Type I IFN Signaling and Exacerbates TLR4-Mediated Septic Shock

  2014cites this paper
• Activation of the Type I Interferon Pathway Is Enhanced in Response to Human Neuronal Differentiation

  2013cites this paper
• Fine tuning type I interferon responses.

  2013cites this paper
• Antiviral Activity of Lambda Interferon in Chickens

  2013cites this paper
• Interferons as biomarkers and effectors: lessons learned from animal models.

  2012cites this paper
• Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer

  2012cites this paper
• The interferons and their receptors—distribution and regulation

  2012cites this paper
• The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate

  2012cites this paper
• Interferon (-alpha, -beta, and -omega) receptor 2 (IFNAR2) is a prognostic biomarker for lung cancer

  2011cites this paper
• cDNA cloning, genomic structure and mRNA expression pattern of porcine type I interferons receptor 2 gene

  2011cites this paper
• Effects of Interferons α/β on the Proliferation of Human Micro- and Macrovascular Endothelial Cells

  2011cites this paper
• Deregulation of Interferon Signaling in Malignant Cells

  2010cites this paper
• Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1

  2010influential citation
• scVEGF Microbubble Ultrasound Contrast Agents: A Novel Probe for Ultrasound Molecular Imaging of Tumor Angiogenesis

  2010cites this paper
• Role of Differential Expression of Interferon Receptor Isoforms on the Response of Multiple Sclerosis Patients to Therapy with Interferon Beta

  2010cites this paper
• Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.

  2010cites this paper
• Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus

  2009cites this paper
• Upregulation of Myxovirus-resistance Protein A: A Possible Marker of Type I Interferon Induction in Systemic Sclerosis

  2008cites this paper
• Interferon-β Pretreatment of Conventional and Plasmacytoid Human Dendritic Cells Enhances Their Activation by Influenza Virus

  2008cites this paper
• Regulated expression of the interferon-β gene in mice

  2008cites this paper
• Regulated expression of the interferon-beta gene in mice.

  2008cites this paper
• Expression and regulation of IFN / receptor in IFN -treated patients with multiple sclerosis

  2008cites this paper
• A Conserved IFN-α Receptor Tyrosine Motif Directs the Biological Response to Type I IFNs1

  2008cites this paper
• Stat 2-Dependent Regulation of MHC Class II Expression 1

  2007cites this paper
• Type I Interferons in the Treatment of Pancreatic Cancer: Mechanisms of Action and Role of Related Receptors

  2007cites this paper
• STAT activation and differential complex formation dictate selectivity of interferon responses.

  2007cites this paper
• Stat2-Dependent Regulation of MHC Class II Expression1

  2007cites this paper
• Type I Interferon Receptors: Biochemistry and Biological Functions*

  2007cites this paper
• Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.

  2006cites this paper
• Blocking Monoclonal Antibodies Specific for Mouse IFN-α/β Receptor Subunit 1 (IFNAR-1) from Mice Immunized byIn Vivo Hydrodynamic Transfection

  2006cites this paper
• A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-alpha signal in vivo.

  2006cites this paper
• Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.

  2006cites this paper
• Gene-Based Delivery of IFN-β Is Efficacious in a Murine Model of Experimental Allergic Encephalomyelitis

  2006cites this paper
• IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.

  2006cites this paper
• Mx1 and IP-10: Biomarkers to Measure IFN-β Activity in Mice Following Gene-Based Delivery

  2006cites this paper
• IFN-β Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell Growth In vitro

  2006cites this paper
• Role of type I Interferons in the treatment of endocrine and non-endocrine cancers

  2006cites this paper
• Cytokine and growth factor receptors in the nucleus: What's up with that?

  2005cites this paper
• IFN-B Is a Highly Potent Inhibitor of Gastroenteropancreatic Neuroendocrine Tumor Cell Growth In vitro

  2005cites this paper
• Interleukin-10 and related cytokines and receptors.

  2004cites this paper
• Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.

  2004cites this paper
• Interferon-α in systemic lupus erythematosus

  2004cites this paper
• Interferons and Interferon Inhibitory Activity in Disease and Therapy

  2004cites this paper
• Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34‐positive cells and its down‐regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia

  2004cites this paper
• Characterization of the type I interferon locus and identification of novel genes.

  2004cites this paper
• Formation of Human IFN-β Complex with the Soluble Type I Interferon Receptor IFNAR-2 Leads to Enhanced IFN Stability, Pharmacokinetics, and Antitumor Activity in Xenografted SCID Mice

  2004cites this paper
• The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions.

  2004cites this paper
• IFNS and STATs, an Incestuous Relationship

  2003cites this paper
• The Structure of Human Interferon-b-1a (Avonex1®) and its Relation to Activity: A Case Study of the Use of Structural Data in the Arena of Protein Pharmaceuticals

  2003cites this paper
• Free interferon‐α/β receptors in the circulation of patients with adenocarcinoma

  2003cites this paper
• Reactivity of human and porcine natural interferon-alpha producing cells to immunostimulatory DNA

  2003cites this paper
• Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases.

  2003cites this paper
• Improved biological and transcriptional activity of monopegylated interferon-alpha-2a isomers.

  2003cites this paper
• Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.

  2003cites this paper
• Viral infections: their elusive role in regulating susceptibility to autoimmune disease.

  2003cites this paper